Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human (Predicted: Mouse, Rat, Drosophila) |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit Polyclonal antibody to c-Myc (v-myc myelocytomatosis viral oncogene homolog (avian))
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse (Predicted: Rat, Dog, Feline, Pig, Sheep, Chimpanzee, Bovine, Rhesus Monkey) |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region within amino acids 1 and 52 of c-Myc (Uniprot ID#P01106) |
Rabbit polyclonal AKT pS473 antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | This whole rabbit serum was prepared by repeated immunizations with a synthetic peptide corresponding to the C-terminus aa 460-480 of human, mouse, rat and chicken AKT proteins conjugated to KLH. |
AKT1 (C-term) rabbit polyclonal antibody, Serum
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Chicken, Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide -KLH conjugated corresponding to the C-terminus (460-480) of Human, Rat, Mouse and Chicken AKT proteins conjugated to KLH using maleimide. |
Rabbit Polyclonal Antibody against PIK3R1 (N-term L11)
| Applications | IHC, WB |
| Reactivities | Human (Predicted: Mouse, Rat, Bovine) |
| Conjugation | Unconjugated |
| Immunogen | This PI3KR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human PI3KR1. |
Rabbit polyclonal Akt (Ab-129) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of serine 129 (D-N-SP-G-A). |
Active filters
Category
- Antibodies
Reactivities
- Rat
Applications
- WB
Clonalities
- Polyclonal
Pathways
- Endometrial cancer
Filter by
Target Symbol
- EGFR (40)
- AKT1 (35)
- BETA CATENIN (24)
- P53 (21)
- RAF1 (21)
- MEK1 (19)
- HER2 (16)
- ERK1 (13)
- ERK2 (13)
- C-MYC (12)
- BAD (11)
- GSK3 BETA (10)
- PI 3 KINASE P85 ALPHA (10)
- AKT2 (8)
- CASPASE 9 (8)
- FOXO3 (7)
- PTEN (7)
- CYCLIN D1 (6)
- E CADHERIN (6)
- ELK1 (6)
- B RAF (5)
- GRB2 (5)
- NRAS (5)
- AKT3 (4)
- INTEGRIN LINKED KINASE (4)
- MEK2 (4)
- ALPHA 1 CATENIN (3)
- APC (3)
- PDPK1 (3)
- A RAF (2)
- EGF (2)
- LEF1 (2)
- MLH1 (2)
- P21 RAS (2)
- AXIN 2 (1)
- BRAF (1)
- PI 3 KINASE P55 GAMMA (1)
Antibody Hosts
Conjugates
Modifications
Assay Types
Families
- Druggable Genome (342)
- Protein Kinase (198)
- ES Cell Differentiation/IPS (135)
- Transcription Factors (72)
- Transmembrane (64)
- Stem cell relevant signaling - JAK/STAT signaling pathway (58)
- Stem cell - Pluripotency (47)
- Adult stem cells (44)
- Cancer stem cells (40)
- Secreted Protein (40)
- Stem cell relevant signaling - Wnt Signaling pathway (18)
- Induced pluripotent stem cells (15)
- Embryonic stem cells (14)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (12)
- Protease (8)
- Phosphatase (7)
- Stem cell relevant signaling - DSL/Notch pathway (6)